Alnylam Pharmaceuticals (ALNY) Soars: Stock Up 40.9% - Tale of the Tape


Alnylam Pharmaceuticals, Inc. ( ALNY ) was a big mover last session, as its shares rose almost 41% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend for the healthcare company, as the stock is trading above the volatile price range of $59.42 to $66.91 in the past one-month time frame.

In the last 30 days, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Yesterday's price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Alnylam currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Other better-ranked stocks in the medical sector include Gentium S.p.A ( GENT ), Emergent BioSolutions, Inc. ( EBS ) and Actelion Ltd. ( ALIOF ). All three sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>


ALNYLAM PHARMA (ALNY): Free Stock Analysis Report

EMERGENT BIOSOL (EBS): Free Stock Analysis Report

GENTIUM SPA-ADR (GENT): Free Stock Analysis Report

To read this article on click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

This article appears in: Investing , Investing Ideas , Stocks

Referenced Stocks: ALIOF , ALNY , EBS , GENT

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by